Sign inJoin waitlistJoin the waitlist

Pratima Chalasani

Physician · Carle Foundation Hospital

Credentials: · · · · ·

History

Hoopeston Community Memorial Hospital
2020–Present

Hematology and Medical Oncology
Gundersen Lutheran Medical Foundation
2013–2016
Internal Medicine
Southern Illinois University School of Medicine
2009–2012
Siddhartha Medical College
2001–2005

Research

A phase II study of intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer
Cancer Chemotherapy and Pharmacology · 2013 · 17 citations

BS
Bruce Shevlin
1 paper
CC
Cathy Clausen
1 paper
JM
James Malone
1 paper
KR
Kevin Robbins
1 paper
KR
Krishna Rao
1 paper
MD
Muthuswamy Dhiwakar
1 paper · 1 as a resident
OR
Ohad Ronen
1 paper
SK
Sini Kalapurakal
1 paper

Clinical trials

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2028
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032